WASHINGTON, D.C. (April 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today:
“PhRMA is very disappointed with the Indian Supreme Court’s decision to deny a patent on Glivec. This decision...
Next week, biopharmaceutical industry, patient community and academia will convene during PhRMA's Annual Meeting to discuss how we can work together to advance research progress & hope. Share this update & make plans to tune-in live, be a part of the meeting.
likes: 19 | comments: 0
DID YOU KNOW?: There have been 8,200 clinical trials throughout Texas over the last 13 years and more than 914 clinical trials are still recruiting patients. Many of these trials target some of the nation’s most devastating chronic diseases - asthma, heart disease, stroke, cancer, diabetes and men...
likes: 26 | comments: 0
Currently 1:10 American adults have diabetes. As many as 1:3 could suffer from the disease by 2050 if current trends continue. With more than 221 innovative new medicines in development, learn how biopharmaceutical companies are working to address the issue. Share what you are doing to prevent or...
likes: 164 | comments: 14
Traditional measures of #innovation must change to include patient-centered care &personalized medicine. Learn more: http://t.co/qojuz6tg1C
04.02.2013 // Retweets: 7
How can we bring together optimism, creativity, science & patients? This is just one discussion topic during #PhRMA13 http://t.co/FloDL0ODRJ
04.04.2013 // Retweets: 5
Combating #Counterfeit Medicines Is a Global Effort http://t.co/F1IzUp9D1F @ScottLags @SafeMedicines
02.28.2013 // Retweets: 4
How is the invention of the lightbulb like developing new #medicines? Read @pfizer_news guest blog to find out: http://t.co/qojuz6tg1C
04.03.2013 // Retweets: 3
Understanding biomedical #innovation is key to sustaining it. Check out our post on defining #innovation: http://t.co/qojuz6tg1C
04.03.2013 // Retweets: 3
